REG - Surgical Innovations - Appointment of Nominated Adviser and Broker

Surgical InnovationsAnnouncement

03/12/2018 07:05

RNS Number : 0932J
Surgical Innovations Group PLC
03 December 2018
 


 
Surgical Innovations Group plc
("Surgical Innovations" or "the "Company")
 
Appointment of Nominated Adviser and Broker
 
Surgical Innovations (AIM: SUN), the designer and manufacturer of innovative technology for minimally invasive surgery, announces the appointment of Nplus1 Singer Advisory LLP ("N+1 Singer") as Nominated Adviser and sole Broker to the Company with immediate effect.
 
 
For further information contact:
 



Surgical Innovations Group Plc


www.sigroupplc.com




Nigel Rogers, Executive Chairman


Tel: +44 (0)113 230 7597




Melanie Ross, COO and CFO


















Walbrook PR (Financial PR & Investor Relations)


Tel: +44 (0)20 7933 8780 or si@walbrookpr.com




Paul McManus


Mob: +44 (0)7980 541 893




Lianne Cawthorne


Mob: +44 (0)7584 391 303














N+1 Singer - Nominated Adviser and Broker


+44 (0)20 7496 3000




Richard Lindley








Rachel Hayes







 
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
APPFDIFDSFASESF